Shandong Ruifeng Chemical Co Ltd
SZSE:300243
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Shandong Ruifeng Chemical Co Ltd
SZSE:300243
|
CN |
|
Mayfield Group Holdings Ltd
ASX:MYG
|
AU |
|
Uranium Energy Corp
XETRA:U6Z
|
US |
|
China Resources Chemical Innovative Materials Co Ltd
SZSE:301090
|
CN |
|
Shandong Xinhua Pharmaceutical Co Ltd
SZSE:000756
|
CN |
|
Omega Healthcare Investors Inc
NYSE:OHI
|
US |
Balance Sheet
Balance Sheet Decomposition
Shandong Ruifeng Chemical Co Ltd
Shandong Ruifeng Chemical Co Ltd
Balance Sheet
Shandong Ruifeng Chemical Co Ltd
| Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Cash & Cash Equivalents |
6
|
17
|
24
|
162
|
148
|
83
|
132
|
116
|
86
|
37
|
117
|
80
|
108
|
203
|
84
|
208
|
108
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
203
|
84
|
208
|
108
|
|
| Cash Equivalents |
6
|
17
|
24
|
162
|
148
|
83
|
132
|
116
|
86
|
37
|
117
|
80
|
108
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
20
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
71
|
75
|
126
|
193
|
205
|
248
|
274
|
292
|
300
|
394
|
463
|
466
|
425
|
464
|
527
|
550
|
616
|
|
| Accounts Receivables |
52
|
56
|
83
|
100
|
130
|
149
|
174
|
193
|
186
|
175
|
165
|
172
|
188
|
251
|
293
|
289
|
416
|
|
| Other Receivables |
19
|
19
|
44
|
94
|
75
|
98
|
100
|
99
|
113
|
218
|
299
|
295
|
236
|
213
|
234
|
261
|
200
|
|
| Inventory |
34
|
63
|
69
|
88
|
86
|
114
|
101
|
74
|
82
|
83
|
106
|
74
|
128
|
119
|
203
|
217
|
321
|
|
| Other Current Assets |
8
|
18
|
20
|
55
|
19
|
34
|
31
|
245
|
33
|
25
|
34
|
25
|
95
|
89
|
133
|
131
|
209
|
|
| Total Current Assets |
118
|
173
|
239
|
497
|
458
|
479
|
538
|
727
|
501
|
539
|
720
|
646
|
775
|
875
|
947
|
1 105
|
1 255
|
|
| PP&E Net |
45
|
44
|
58
|
61
|
164
|
194
|
249
|
282
|
271
|
251
|
247
|
317
|
436
|
718
|
873
|
948
|
908
|
|
| PP&E Gross |
45
|
44
|
58
|
61
|
164
|
194
|
249
|
282
|
271
|
251
|
247
|
317
|
436
|
718
|
873
|
948
|
908
|
|
| Accumulated Depreciation |
11
|
18
|
26
|
37
|
49
|
66
|
80
|
102
|
134
|
169
|
188
|
214
|
240
|
268
|
315
|
345
|
447
|
|
| Intangible Assets |
10
|
10
|
11
|
11
|
22
|
60
|
59
|
71
|
70
|
69
|
67
|
65
|
74
|
76
|
99
|
97
|
94
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
150
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
5
|
4
|
|
| Other Long-Term Assets |
1
|
1
|
1
|
1
|
3
|
7
|
11
|
15
|
15
|
19
|
21
|
18
|
17
|
19
|
21
|
19
|
25
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
0
|
0
|
0
|
0
|
|
| Total Assets |
175
N/A
|
228
+30%
|
309
+36%
|
571
+85%
|
647
+13%
|
740
+14%
|
858
+16%
|
1 245
+45%
|
857
-31%
|
878
+2%
|
1 057
+20%
|
1 046
-1%
|
1 317
+26%
|
1 688
+28%
|
1 942
+15%
|
2 174
+12%
|
2 285
+5%
|
|
| Liabilities | ||||||||||||||||||
| Accounts Payable |
18
|
20
|
29
|
32
|
30
|
58
|
37
|
50
|
40
|
57
|
54
|
90
|
95
|
133
|
138
|
131
|
121
|
|
| Accrued Liabilities |
0
|
3
|
0
|
1
|
3
|
2
|
3
|
4
|
4
|
5
|
20
|
16
|
16
|
22
|
18
|
19
|
19
|
|
| Short-Term Debt |
38
|
50
|
113
|
145
|
199
|
228
|
323
|
289
|
282
|
234
|
289
|
196
|
364
|
177
|
315
|
333
|
413
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
2
|
4
|
4
|
2
|
0
|
0
|
0
|
0
|
9
|
69
|
41
|
78
|
|
| Other Current Liabilities |
82
|
73
|
40
|
44
|
33
|
43
|
53
|
421
|
41
|
59
|
78
|
59
|
70
|
59
|
83
|
76
|
69
|
|
| Total Current Liabilities |
138
|
147
|
182
|
221
|
263
|
332
|
419
|
767
|
369
|
355
|
441
|
361
|
545
|
400
|
623
|
600
|
701
|
|
| Long-Term Debt |
0
|
10
|
10
|
10
|
10
|
8
|
5
|
2
|
0
|
0
|
0
|
0
|
0
|
386
|
375
|
426
|
442
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
17
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
3
|
2
|
10
|
12
|
11
|
10
|
11
|
13
|
15
|
10
|
9
|
8
|
9
|
7
|
5
|
|
| Total Liabilities |
138
N/A
|
157
+13%
|
195
+24%
|
233
+20%
|
283
+22%
|
352
+24%
|
435
+23%
|
779
+79%
|
380
-51%
|
367
-3%
|
455
+24%
|
371
-18%
|
571
+54%
|
794
+39%
|
1 006
+27%
|
1 033
+3%
|
1 148
+11%
|
|
| Equity | ||||||||||||||||||
| Common Stock |
5
|
40
|
40
|
54
|
86
|
104
|
207
|
206
|
206
|
207
|
211
|
232
|
232
|
232
|
232
|
250
|
250
|
|
| Retained Earnings |
30
|
9
|
53
|
92
|
118
|
142
|
177
|
220
|
231
|
259
|
339
|
392
|
454
|
519
|
552
|
638
|
635
|
|
| Additional Paid In Capital |
2
|
22
|
22
|
192
|
160
|
147
|
42
|
42
|
42
|
45
|
75
|
63
|
65
|
68
|
76
|
178
|
178
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
5
|
3
|
2
|
2
|
0
|
24
|
12
|
6
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
75
|
75
|
75
|
75
|
|
| Total Equity |
37
N/A
|
71
+93%
|
115
+61%
|
338
+194%
|
364
+8%
|
388
+7%
|
423
+9%
|
467
+10%
|
477
+2%
|
511
+7%
|
602
+18%
|
675
+12%
|
746
+10%
|
894
+20%
|
935
+5%
|
1 141
+22%
|
1 138
0%
|
|
| Total Liabilities & Equity |
175
N/A
|
228
+30%
|
309
+36%
|
571
+85%
|
647
+13%
|
740
+14%
|
858
+16%
|
1 245
+45%
|
857
-31%
|
878
+2%
|
1 057
+20%
|
1 046
-1%
|
1 317
+26%
|
1 688
+28%
|
1 942
+15%
|
2 174
+12%
|
2 285
+5%
|
|
| Shares Outstanding | ||||||||||||||||||
| Common Shares Outstanding |
113
|
113
|
113
|
113
|
226
|
223
|
226
|
226
|
226
|
228
|
228
|
229
|
231
|
232
|
232
|
250
|
250
|
|